|
Market Closed -
NYSE
16:00:00 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 3.640 USD | -13.33% |
|
-10.57% | -42.04% |
| 09-14 | Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment | DJ |
| 09-14 | Armata Pharmaceuticals' AP-SA02 Gets FDA Breakthrough Therapy Designation | MT |
| Market Cap | 135M 119M 112M 102M 191M 12.96B 192M 1.34B 520M 6.61B 508M 497M 21.43B | P/E 2026 * |
-1.95x | P/E 2027 * | -2.52x |
|---|---|---|---|---|---|
| Enterprise Value | 135M 119M 112M 102M 191M 12.96B 192M 1.34B 520M 6.61B 508M 497M 21.43B | EV / Sales 2026 * |
31.8x | EV / Sales 2027 * | 49.2x |
| Free-Float |
32.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ARMP | Delayed | |
Tradegate
| TG1N | Real-time | |
CBOE
| ARMP | Real-time | |
Deutsche Boerse AG
| TG1N | Delayed | |
Börse Stuttgart
| TG1N | Delayed | |
Boerse Muenchen
| TG1N | Real-time |
| 1 day | -13.33% | ||
| 1 week | -10.57% | ||
| Current month | -33.94% | ||
| 1 month | -28.63% | ||
| 3 months | -48.07% | ||
| 6 months | -55.01% | ||
| Current year | -42.04% |
| 1 week | 3.6 | 4.56 | |
| 1 month | 3.6 | 6.64 | |
| Current year | 3.48 | 14.98 | |
| 1 year | 2.94 | 16.34 | |
| 3 years | 0.9 | 16.34 | |
| 5 years | 0.83 | 16.34 | |
| 10 years | 0.83 | 16.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 70 | 2023-07-10 |
David House
DFI | Director of Finance/CFO | 42 | 2024-08-15 |
Peter Hubbard
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Patti
BRD | Director/Board Member | 62 | 2019-05-08 |
| Director/Board Member | 66 | 2020-02-11 | |
Odysseas Kostas
BRD | Director/Board Member | 51 | 2020-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/10/26 | Tax | Chief Executive Officer | -14,041 | 0.0382% | ||
| 4/24/26 | Free | Director | 51,280 | 0.1400% | ||
| 3/14/26 | Tax | Public Communications Manager | 1,030 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -13.33% | -10.57% | +19.34% | +35.82% | 135M | ||
| +0.06% | +6.49% | +60.29% | +111.13% | 74.18B | ||
| -0.43% | -4.17% | +33.73% | +74.31% | 59.55B | ||
| -2.05% | -3.46% | -18.60% | +352.20% | 25.84B | ||
| -2.39% | +2.74% | +0.19% | -5.91% | 24.73B | ||
| -1.11% | +1.34% | +21.77% | -9.80% | 20.87B | ||
| +1.29% | -2.49% | +152.11% | +333.06% | 15.32B | ||
| -2.44% | -0.09% | +42.50% | +164.11% | 14.06B | ||
| -3.91% | -4.91% | -14.10% | +779.68% | 13.12B | ||
| -1.12% | -3.04% | +15.72% | +234.56% | 11.85B | ||
| Average | -2.55% | -1.42% | +31.30% | +206.92% | 25.97B | |
| Weighted average by Cap. | -0.93% | +0.70% | +36.17% | +161.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.25M 3.73M 3.51M 3.21M 5.99M 407M 6.04M 42.12M 16.33M 208M 15.96M 15.61M 673M | 2.75M 2.41M 2.27M 2.07M 3.88M 263M 3.9M 27.25M 10.56M 134M 10.33M 10.1M 435M |
| Net income | -76.6M -67.23M -63.2M -57.78M -108M -7.34B -109M -759M -294M -3.74B -288M -281M -12.13B | -72M -63.19M -59.4M -54.31M -101M -6.9B -102M -714M -277M -3.52B -270M -264M -11.4B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | US$3.640 | -13.33% | 287,063 |
| 26-09-22 | US$4.200 | -1.41% | 128,357 |
| 26-09-21 | US$4.260 | +1.91% | 82,899 |
| 26-09-18 | US$4.180 | +1.95% | 160,607 |
| 26-09-17 | US$4.100 | +0.74% | 253,540 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARMP Stock
Select your edition
All financial news and data tailored to specific country editions

















